We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Immunology
Using mice to unravel the mysteries of COVID-19 disease

Using mice to unravel the mysteries of COVID-19 disease

Published Date May 20, 2021

Nadia Rosenthal, Ph.D.

Previous Video

JAX Antibody Development Summit - Dave Serreze

Dr. Dave Serreze, Professor, The Jackson Laboratory, presents Targeting Autoreactive B-cells Contributing to Type 1 Diabetes Development as part of The Jackson Laboratory's Antibody Drug Development S
Next Video

The Importance of Testing Mice for COVID-19 Variants of Concern

Jim Fahey, Ph.D.

Other content in this Stream

almost 2 years ago
PEGS EU 2023 - Translational Humanized Models for Immunotherapy Drug Development

Read Flipbook
over 1 year ago
Rapid In Vivo Evaluation of Immuno-Modulatory Therapies Using Hu-PBMC NSG™ Mice

Learn about Hu-PBMC NSG models that can be used to test the efficacy of human T cell immunomodulatory therapeutics for graft-versus-host disease (GvHD), autoimmune disorders, and cancer.

Watch Video
about 2 years ago
The Application of Humanized Mice in Manipulation of Myeloid Cells - Dr. Ali Roghanian

Read Flipbook
about 2 years ago
In Vivo Platforms for Autoimmune Pharmacology: MS-EAE Capabilities

Watch this webinar to learn about Experimental Autoimmune Encephalomyelitis (EAE), which serves as the gold standard preclinical model for MS research.

Watch Video
about 2 years ago
CRS Highlights for EU Symposium

Read Flipbook
about 2 years ago
CAR T studies with significantly delayed onset of GvHD

Assessing efficacy and toxicity in CAR-T studies in an accessible translational model. The Jackson Laboratory's in vivo PBMC-humanized mouse platform provides a wider window to look at cytokine releas

Watch Video
almost 3 years ago
Potency of PD-1+CTLA-4 Bispecific or Combination in a Humanized Mouse Model

Presented by Richard Stebbings, Ph.D., Senior Director Oncology Safety Science, AstraZeneca

Read Flipbook
almost 3 years ago
Of Mice and Men - FcRn Biology and Its Implications in a Therapeutic Perspective - Jan Terje Andersen, Ph.D.

Of mice and men - FcRn biology and its implications in a therapeutic perspective Presented by Jan Terje Andersen, Ph.D. - Professor in Biomedical Innovation, University of Oslo, Co-founder, Authera,

Watch Video
almost 3 years ago
Preclinical Assessment of Engineered Immunoglobulins in Immune Humanized Mice - Brian Soper, Ph.D.

Preclinical Assessment of Engineered Immunoglobulins in Immune-humanized Mice Presented by Brian Soper, Ph.D. - Senior Scientific Engagement Manager, The Jackson Laboratory, Bar Harbor, USA Presen

Watch Video
about 3 years ago
Mouse Models of Coronavirus Infection

In this webinar, we discuss upcoming and established strains in the JAX COVID-19 Model Portfolio, in the context of in vivo findings with SARS-CoV2 and related viruses.

Watch Video
over 3 years ago
JAX Tech Talk Episode 51: Let’s Talk Accelerating Research with JAX’s GvHD Platform (Mar. 1, 2022)

March 1, 2022 - In this episode, the JAX Tech Talk Team welcomes Prabir Banerjee to discuss the JAX GvHD platform and its value in accelerating  your preclinical research studies.

Watch Video
over 3 years ago
NOD/scid IL-2Rγnull Mice Reconstituted with Peripheral Blood Mononuclear Cells of Crohn’s Disease

Veronika Weß leads an informative discussion on the use of the immune-humanized mouse platform to explore the biological underpinnings of inflammatory bowel disease (IBD).

Watch Video
almost NaN years ago
Studying Complex, Systemic Immune Responses in Humanized Mice

Although many mammals have immune systems that share important characteristics with humans, certain immune cell types and phenomena are unique to us. As a result, it has been difficult to design...

Learn More
over 3 years ago
JAX Tech Talk Episode 49: Let’s Talk COVID Models - 2022 Updates (Feb. 1, 2022)

February 1, 2022 - With COVID-19 research ever-evolving and novel research results becoming available, Team JAX Tech Talk looks to discuss the newest advancements in the field.

Watch Video
almost 4 years ago
JAX Tech Talk Episode 44: Let's Talk Grants for Genetic Background’s Impact on Translatability (Oct. 5, 2021)

October 5, 2021 - Is your treatment robust enough to "work" in different genetic backgrounds? Are your preclinical studies assessing translatability? In this episode, we will explore: how J:DO mice m

Watch Video
almost 4 years ago
JAX Tech Talk Episode 43: Let’s Talk Assessing Efficacy of GvHD Therapeutics (Sept. 14, 2021)

September 14, 2021 - In this episode, we discuss how the xenogeneic GvHD model in NSG mice aligns with your drug development pipeline.

Watch Video
almost 4 years ago
GvHD Efficacy Study Fact Sheet

An example of study information provided when conducting a GvHD study with the Jackson Laboratory. This example shows Bispecific Antibodies in comparison with Abatacept.

Read Flipbook
almost 4 years ago
Important Considerations for Generating Genetic Humanized Mouse Models

The term humanization is used, to much confusion, to mean several different things in mouse research. While broad in scope and technique, all humanized mouse models share a common goal – to better lev

Learn More
Genetically Diverse Mouse Models for Every Stage of the Research Pipeline

Mouse research is often performed in genetically-defined inbred mouse strains, where each mouse within a strain is virtually identical to one another.

Learn More
about 4 years ago
JAX Antibody Development Summit - Dave Serreze

Dr. Dave Serreze, Professor, The Jackson Laboratory, presents Targeting Autoreactive B-cells Contributing to Type 1 Diabetes Development as part of The Jackson Laboratory's Antibody Drug Development S

Watch Video

Recommended for you

Return to Home